GB0404105D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0404105D0
GB0404105D0 GBGB0404105.9A GB0404105A GB0404105D0 GB 0404105 D0 GB0404105 D0 GB 0404105D0 GB 0404105 A GB0404105 A GB 0404105A GB 0404105 D0 GB0404105 D0 GB 0404105D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0404105.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0404105.9A priority Critical patent/GB0404105D0/en
Publication of GB0404105D0 publication Critical patent/GB0404105D0/en
Priority to PCT/EP2005/001937 priority patent/WO2005080349A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0404105.9A 2004-02-24 2004-02-24 Novel compounds Ceased GB0404105D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0404105.9A GB0404105D0 (en) 2004-02-24 2004-02-24 Novel compounds
PCT/EP2005/001937 WO2005080349A1 (fr) 2004-02-24 2005-02-22 Derives de pyrimidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0404105.9A GB0404105D0 (en) 2004-02-24 2004-02-24 Novel compounds

Publications (1)

Publication Number Publication Date
GB0404105D0 true GB0404105D0 (en) 2004-03-31

Family

ID=32050791

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0404105.9A Ceased GB0404105D0 (en) 2004-02-24 2004-02-24 Novel compounds

Country Status (2)

Country Link
GB (1) GB0404105D0 (fr)
WO (1) WO2005080349A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781593B2 (en) 2006-09-14 2010-08-24 Hoffmann-La Roche Inc. 5-phenyl-nicotinamide derivatives
EP2415765A4 (fr) 2009-03-30 2012-08-15 Astellas Pharma Inc Composé pyrimidine
EP2872138A4 (fr) * 2012-07-13 2016-04-20 Cleveland Clinic Foundation Agonistes neuroprotecteurs des récepteurs cb2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2230894A1 (fr) * 1995-09-01 1997-03-13 Signal Pharmaceuticals, Inc. Carboxamides de pyrimidine et composes associes, et methodes de traitement d'etats inflammatoires
EP1361879A1 (fr) * 2001-02-20 2003-11-19 Bristol-Myers Squibb Company Derives de 2,4-disubstitue pyrimidine-5-carboxamide en tant que modulateur des canaux potassium kcnq
TWI231757B (en) * 2001-09-21 2005-05-01 Solvay Pharm Bv 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
AU2003260436A1 (en) * 2002-08-21 2004-03-11 Glaxo Group Limited Pyrimidine compounds

Also Published As

Publication number Publication date
WO2005080349A1 (fr) 2005-09-01

Similar Documents

Publication Publication Date Title
EP1718638A4 (fr) Nouveaux composes
GB0400812D0 (en) Novel compounds
GB0409744D0 (en) Novel compounds
GB0405628D0 (en) Novel compounds
GB0402140D0 (en) Novel compounds
GB0402496D0 (en) Novel compounds
EP1805132A4 (fr) Nouveaux composes
EP1796793A4 (fr) Nouveaux composes
GB0402357D0 (en) Novel compounds
GB0408083D0 (en) Novel compounds
GB0402812D0 (en) Novel compounds
GB0402355D0 (en) Novel compounds
GB0402356D0 (en) Novel compounds
GB0402380D0 (en) Novel compounds
GB0404105D0 (en) Novel compounds
GB0402114D0 (en) Novel compounds
GB0411167D0 (en) Novel compounds
GB0402144D0 (en) Novel compounds
GB0402145D0 (en) Novel compounds
GB0402134D0 (en) Novel compounds
GB0402115D0 (en) Novel compounds
GB0400885D0 (en) Novel compounds
GB0402110D0 (en) Novel compounds
GB0401727D0 (en) Novel compounds
GB0400901D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)